July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Is Polypoidal Choroidal Vasculopathy differentiated from Age-related Macular Degeneration?
Author Affiliations & Notes
  • Handan Akil
    Ophthalmology, University of Liverpool, Liverpool, Merseyside, United Kingdom
  • Tony Fang
    Ophthalmology, UBC Vancouver General Hospital, Vancouver, British Columbia, Canada
  • Theresa Wiens
    Ophthalmology, UBC Vancouver General Hospital, Vancouver, British Columbia, Canada
  • David Maberley
    Ophthalmology, UBC Vancouver General Hospital, Vancouver, British Columbia, Canada
  • Eduardo Vitor Navajas
    Ophthalmology, UBC Vancouver General Hospital, Vancouver, British Columbia, Canada
  • Footnotes
    Commercial Relationships   Handan Akil, None; Tony Fang, None; Theresa Wiens, None; David Maberley, None; Eduardo Navajas, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 68. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Handan Akil, Tony Fang, Theresa Wiens, David Maberley, Eduardo Vitor Navajas; Is Polypoidal Choroidal Vasculopathy differentiated from Age-related Macular Degeneration?. Invest. Ophthalmol. Vis. Sci. 2019;60(9):68.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the diagnosis and treatment of polypoidal choroidal vasculopathy (PCV) and age-related macular degeneration (AMD) in Chinese and Caucasian Canadian patients.

Methods : Retrospective chart review (431 charts). 37 eyes from 37 Chinese patients and 394 eyes from 394 Caucasian patients who were newly diagnosed with either AMD or PCV and had more than 1 year of follow-up were included. All newly diagnosed AMD patients presenting to the Retina Service of 4 retina specialists, between April, 2008, and September 30, 2017, were reviewed.

Results : PCV was diagnosed in 17.6% of Chinese Canadians (6/37 eyes) and 12.8% of Caucasian Canadians (49/394 eyes). Indocyanine green angiography (ICGA) was used to diagnose PCV in 5.4% of Chinese Canadians and 0.5% of Caucasian Canadians. This is close to the expected prevalence published in the literature for these two groups.

Conclusions : Despite the underutilization of ICG, PCV was still being diagnosed in our population. A careful qualitative analysis of the tomographic findings may help clinicians to distinguish between PCV and occult CNV, decreasing the need for ICGA.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×